Lower Respiratory Tract Infection (LRTI) – A Comprehensive Guide
Overview
A lower respiratory tract infection (LRTI) involves the airways below the larynx, primarily the trachea, bronchi, bronchioles, and the lung tissue itself (bronchitis, bronchiolitis, and pneumonia). LRTIs are among the most common reasons for physician visits and hospitalizations worldwide.
- Global burden: The World Health Organization estimates that LRTIs accounted for ~3 million deaths in 2019, representing ~15 % of all deaths in children under five and ~5 % in adults.[1]
- Who it affects: Everyone can develop an LRTI, but infants, older adults (≥ 65 years), immunocompromised persons, and those with chronic lung disease are at highest risk.
- Seasonality: Incidence peaks in colder months in temperate regions because viruses survive longer in dry air and people spend more time indoors.
Symptoms
The presentation varies with the specific type of LRTI (e.g., acute bronchitis vs. bacterial pneumonia) and the patient’s age and comorbidities.
General symptoms (common to most LRTIs)
- Cough: Often productive (produces sputum) but may be dry in early viral infections.
- Shortness of breath (dyspnea): May be mild to severe, worsens with exertion.
- Chest discomfort: A feeling of tightness, heaviness, or pain that can be pleuritic (sharp on breathing).
- Fever: Usually low‑grade in viral bronchitis (99‑101 °F/37.2‑38.3 °C) and higher in bacterial pneumonia (> 102 °F/38.9 °C).
- Fatigue and malaise: General feeling of being unwell.
- Wheezing or noisy breathing: More common in bronchitis, bronchiolitis, or asthma‑exacerbated LRTI.
Symptoms suggestive of specific etiologies
- Purulent (yellow/green) sputum: Suggests bacterial infection, though not definitive.
- Foul‑smelling sputum: May indicate anaerobic bacteria (e.g., aspiration pneumonia).
- Rapid breathing (tachypnea): Particularly concerning in infants and older adults.
- Chest pain that worsens on deep inspiration: Classic for pleuritic involvement, often seen in bacterial pneumonia.
- Night sweats, weight loss, or chronic cough > 8 weeks: May point to tuberculosis or atypical organisms.
Causes and Risk Factors
Infectious agents
- Viruses (≈ 50‑70 % of cases): Influenza, respiratory syncytial virus (RSV), human metapneumovirus, rhinovirus, parainfluenza, adenovirus, and, seasonally, SARS‑CoV‑2.
- Bacteria (≈ 20‑30 %): Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus (including MRSA), and atypicals such as Mycoplasma pneumoniae, Chlamydophila pneumoniae, Legionella pneumophila.
- Fungi (rare, but important in immunocompromised): Pneumocystis jirovecii, Aspergillus spp.
Key risk factors
- Age: < 5 years and ≥ 65 years.
- Smoking: Damages airway cilia and impairs mucociliary clearance.
- Chronic lung disease: COPD, asthma, bronchiectasis, cystic fibrosis.
- Cardiovascular disease, diabetes, chronic kidney disease.
- Immunosuppression: HIV/AIDS, chemotherapy, solid‑organ transplant, chronic corticosteroids.
- Environmental exposures: Air pollution, indoor biomass fuel, crowded living conditions.
- Recent viral illness: Influenza or COVID‑19 can predispose to secondary bacterial pneumonia.
Diagnosis
Clinicians combine a careful history, physical examination, and targeted investigations.
History & Physical Exam
- Onset, duration, and progression of cough and fever.
- Exposure history (travel, sick contacts, occupational hazards).
- Physical findings: crackles (rales), wheezes, decreased breath sounds, use of accessory muscles, fever, tachycardia.
Laboratory & Imaging Tests
- Chest X‑ray: First‑line imaging; detects infiltrates, consolidation, pleural effusion.
- Computed tomography (CT) scan: Reserved for complicated cases or when X‑ray is non‑diagnostic.
- Complete blood count (CBC): Leukocytosis suggests bacterial infection; lymphocytosis may point to viral or atypical.
- Inflammatory markers: C‑reactive protein (CRP) and procalcitonin help differentiate bacterial from viral etiologies.
- Sputum culture & Gram stain: Useful in severe or hospitalized patients.
- Blood cultures: Indicated for high‑fever, sepsis, or immunocompromised hosts.
- Rapid viral antigen tests / PCR panels: Detect influenza, RSV, SARS‑CoV‑2, and other respiratory viruses.
- Urinary antigen tests: For Legionella pneumophila and Streptococcus pneumoniae.
- Pulmonary function tests: Not for acute diagnosis but helpful in chronic lung disease evaluation.
Treatment Options
General principles
- Supportive care is the cornerstone for viral LRTIs.
- Antibiotics are reserved for confirmed or strongly suspected bacterial infection.
- Treatment should be individualized based on severity, comorbidities, and local resistance patterns.
Medications
- Antibiotics (bacterial LRTIs):
- Outpatient, uncomplicated pneumonia: Amoxicillin 1 g PO q12h for 5–7 days (or doxycycline 100 mg PO q12h if allergic).
- Risk factors for atypical pathogens: A macrolide (azithromycin 500 mg PO daily) or respiratory fluoroquinolone (levofloxacin 750 mg PO daily) for 5 days.
- Hospitalized, severe pneumonia: IV β‑lactam (ceftriaxone 1‑2 g IV q24h) plus a macrolide, or monotherapy with a respiratory fluoroquinolone.
- Antivirals (selected viral LRTIs):
- Oseltamivir 75 mg PO BID for influenza (within 48 h of symptom onset).
- Remdesivir IV for hospitalized COVID‑19 patients who meet criteria (per NIH guidelines).
- Bronchodilators & inhaled corticosteroids: For patients with underlying asthma or COPD experiencing wheeze or bronchospasm.
- Analgesics/Antipyretics: Acetaminophen or ibuprofen for fever and pain.
- Adjunctive therapy: Mucolytics (e.g., guaifenesin) may aid sputum clearance in bronchitis.
Procedures & Hospital Care
- Supplemental oxygen to maintain SpO₂ ≥ 92 % (≥ 88 % in COPD).
- Intravenous fluids for dehydration.
- Mechanical ventilation for respiratory failure.
- Chest physiotherapy & incentive spirometry to prevent atelectasis.
- Bronchoscopy if there is suspicion of obstruction, foreign body, or to obtain deep respiratory samples.
Lifestyle & Home Care
- Increase fluid intake (water, broth) to keep secretions thin.
- Rest and gradual return to activity.
- Humidified air (cool‑mist humidifier) to soothe irritated airways.
- Smoking cessation – essential for recovery and prevention.
Living with Lower Respiratory Tract Infection
Even after the acute phase resolves, many people experience lingering fatigue or cough. Below are practical tips to manage day‑to‑day life.
- Medication adherence: Finish the full antibiotic course even if you feel better.
- Monitor symptoms: Keep a daily log of temperature, breathlessness, and sputum changes.
- Gradual activity: Start with short walks; avoid heavy exertion until you can speak full sentences without stopping.
- Nutrition: Eat protein‑rich foods (lean meats, legumes, dairy) to support immune recovery.
- Hydration: Aim for ≥ 2 L fluids per day unless fluid‑restricted.
- Vaccinations: Stay up‑to‑date with influenza, COVID‑19, pneumococcal, and pertussis vaccines (see Prevention section).
- Follow‑up appointments: Usually within 7‑10 days to ensure radiographic resolution and to adjust treatment if needed.
Prevention
Vaccination
- Annual influenza vaccine – reduces risk of influenza‑related LRTI by up to 60 %.[2]
- Pneumococcal conjugate (PCV13) and polysaccharide (PPSV23) vaccines – especially for adults ≥ 65 years, smokers, and those with chronic disease.
- COVID‑19 vaccine series and boosters as recommended.
- Tdap (tetanus, diphtheria, pertussis) – pertussis can cause severe LRTI in infants and the elderly.
General hygiene
- Hand washing with soap for ≥ 20 seconds or using an alcohol‑based sanitizer.
- Cover mouth and nose with a tissue or elbow when coughing/sneezing.
- Avoid close contact with anyone showing respiratory symptoms, especially during outbreaks.
- Regular cleaning of high‑touch surfaces.
Lifestyle modifications
- Quit smoking; use nicotine‑replacement or prescription aids.
- Limit exposure to indoor pollutants (wood smoke, vapor rubs) and outdoor air pollution.
- Maintain a healthy weight and stay physically active – improves lung reserve.
- Manage chronic conditions (diabetes, heart disease) aggressively.
Complications
If an LRTI is not treated promptly or the patient has significant comorbidities, several serious complications can arise.
- Pneumonia progression: Diffuse alveolar damage, respiratory failure, sepsis.
- Empyema: Collection of pus in the pleural space; may require drainage.
- Abscess formation: Localized lung tissue necrosis, often due to Staphylococcus aureus.
- Acute respiratory distress syndrome (ARDS): Life‑threatening inflammation causing severe hypoxemia.
- Cardiac complications: Myocardial infarction or heart failure exacerbation due to systemic inflammation.
- Chronic lung sequelae: Bronchiectasis or chronic obstructive changes after repeated infections.
- Secondary bacterial infection after viral LRTI: Particularly after influenza or COVID‑19.
When to Seek Emergency Care
Call 911 or go to the nearest emergency department if you notice any of the following:
- Shortness of breath that worsens rapidly or prevents you from speaking full sentences.
- Chest pain that is sharp, pressure‑like, or radiates to the arm, jaw, or back.
- Blue or gray discoloration of lips, fingertips, or face.
- Severe fever (> 104 °F / 40 °C) or a fever that does not improve with antipyretics.
- Rapid heart rate (> 130 bpm) or irregular heartbeat.
- Confusion, drowsiness, or inability to stay awake.
- Persistent vomiting or inability to keep fluids down.
- Signs of dehydration (dry mouth, decreased urine output, dizziness).
These signs may indicate respiratory failure, sepsis, or a serious complication requiring immediate medical intervention.
References
- World Health Organization. Lower Respiratory Infections. 2022. https://www.who.int/news-room/fact-sheets/detail/pneumonia
- Centres for Disease Control and Prevention. Influenza Antiviral Medications: Summary for Clinicians. 2023. https://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm
- Mayo Clinic. Pneumonia. Updated 2024. https://www.mayoclinic.org/diseases‑conditions/pneumonia/symptoms-causes/syc‑20354204
- National Institute of Allergy and Infectious Diseases. Treatment Guidelines for Community‑Acquired Pneumonia. 2023. https://www.cdc.gov/pneumonia/clinical-guidelines.html
- Cleveland Clinic. Bronchitis: Symptoms, Causes, and Treatment. 2024. https://my.clevelandclinic.org/health/diseases/16770-bronchitis